RESEARCH ARTICLE

Biostatistical Analysis on Anti-Hypertension Herbs

Xia Jiang.1 Bin Zhao.1,2* 

• .1Hospital, Hubei University of Technology, Wuhan, Hubei, China 
• .2School of Science, Hubei University of Technology, Wuhan, Hubei, China

Corresponding Author: Bin Zhao, School of Science, Hubei University of Technology, Wuhan, Hubei, China. Tel./Fax: +86 130 2851 7572. E-mail: [email protected] 

Received: October 17, 2022                                        Published: November 05, 2022 

Citation: Bin Z. Biostatistical Analysis on the Regulation of Blood Pressure. Int J Complement Intern Med. 2022;2(1):23– 42. 

Copyright: ©2022 Zhao. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and build upon your work non-commercially.

Abstract 

Hypertension is one of the most common diseases in the current era. With the increase in life pressures, the number of people with high blood pressure is constantly increasing. Multiple types of medical drugs are used to treat high blood pressure, but despite their use in treatment, they have many side effects, so with the beginning of the twentieth century, the World Health Organization sought to urge the use of alternative medicine in thetreatment of many diseases because of its characteristics that make it superior on medical drugs, the most important of which is that it has no side effects. The purpose of this study was to determine the effectiveness of Fashareen on the regulation of blood pressure. 

Material and Methods The study was designed to include hypertensive patients, where 30 participants were taken from OPD of government and private hospitals in Faisalabad according to the inclusionand exclusion criteria of the study. Consent was taken from individuals for an assessment and intervention procedure. A recommended dose of 1 tablet of Fashareen twice a day was given to the patients in 12 hours apart period, and after that, we collected the data again from the patients e.g. Blood pressure and heartbeats. 

Results Significant change in blood pressure values after the treatment in a group in addition to a significant decrease in heart rate values after the treatment in a group. 

Conclusion Fashareen is quite effective in controlling blood stress. 

Keywords: Hypertension, Fashareen, OPD, Blood Pressure, Heartbeats

References 

1. El Sayed K, Macefield VG, Hissen SL, et al. Rate of rise in diastolic blood pressure influences vascular sympathetic response to mental stress. J Physiol. 2016;594(24):7465–7482. 

2. Westerweel PE, Rienks R, Taher A. Diving with hypertension and antihypertensive drugs. Diving Hyperb Med. 2020; 50(1):49–53. 

3. Rippe JM. Lifestyle Medicine: The Health Promoting Power of Daily Habits and Practices. Am J Lifestyle Med. 2018; 12(6):499–512. 

4. Singh S, Shankar R, Singh GP. Prevalence and associated risk factors of hypertension: a cross– sectional study in urban Varanasi. Int J Hypertens. 2017;2017:5491838. 

5. Martín Timón I, Sevillano Collantes C, Segura Galindo A. Type 2 diabetes and cardiovascular disease: Have all risk factors the same strength? World J Diabetes. 2014;5(4):444–470. 

6. Chobanian AV, Bakris GL, Black HR, et al. Seventh report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure. Hypertension. 2003;42(6):1206–1252. 

7. Giuseppe Mancia, Robert Fagard, Krzysztof Narkiewicz, et al. ESH/ESC Guidelines for the management of arterial hypertension: The Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). European Heart Journal. 2013;34(28):2159–2219. 

8. Wang Y, Wang QJ. The prevalence of pre hypertension and hypertension among US adults according to the new joint national committee guidelines: new challenges of the old problem. Arch Intern Med. 2004;164:2126–2134. 

9. Chobanian AV, Bakris GL, Black HR. The seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure: the JNC 7 report. Jama. 2003;289(19):2560–2571. 

10. Sengul S, Akpolat T, Erdem Y, et al. Changes in hypertension prevalence, awareness, treatment, and control rates in Turkey from 2003 to 2012. J Hypertens. 2016;34(6):1208–1217. 

11. Bowe B, Xie Y, Li T, et al. The 2016 global and national burden of diabetes mellitus attributable to PM2.5 air pollution. Lancet Planet. 2018;2:e301– 312. 

12. Burnett R, Chen H, Szyszkowicz M, et al. Global estimates of mortality associated with long–term exposure to outdoor fine particulate matter. PNAS. 2018;115(38):9592–9597. 

13. Carey RM, Muntner P, Bosworth HB. Prevention and Control of Hypertension: JACC Health Promotion Series. J Am Coll Cardiol. 2018;72(11):1278–1293. 

14. Kazi AM, Qazi SA, Ahsan N, et al. Current Challenges of Digital Health Interventions in Pakistan: Mixed Methods Analysis. J Med Internet Res. 2020;22(9):e21691. 

15. Maj M, van Os J, De Hert M, et al. The clinical characterization of the patient with primary psychosis aimed at personalization of management. World Psychiatry. 2021;20(1):4–33. 

16. Saeed AA, Al Hamdan NA, Bahnassy AA, et al. Prevalence, Awareness, Treatment, and Control of Hypertension among Saudi Adult Population: A National Survey. Int J Hypertens. 2011; 2011:174135. 

17. Naderi SH, Bestwick JP, Wald DS. Adherence to drugs that prevent cardiovascular disease: meta–analysis on 376,162 patients. Am J Med. 2012;125(9):882–887. 

18. Mohamad M, Moussally K, Lakis C, et al. Self–reported medication adherence among patients with diabetes or hypertension, Médecins Sans Frontières Shatila refugee camp, Beirut, Lebanon: A mixed methods study. PLoS One. 2021;10: 16(5):e0251316. 

19. Abosamak NER, Shahin MH. Beta 2 Receptor Agonists/Antagonists. In: StatPearls. Treasure Island (FL): StatPearls Publishing; 2022. 

20. Farzam K, Jan A. Beta Blockers. In: StatPearls. Treasure Island (FL): StatPearls Publishing; 2022. 

21. Oudhia P, Tripathi RS. Identification, cultivation and export of important medicinal plants. In Proc. National Seminar on Horticulture Development in Chhattisgarh: Vision and Vistas. Indira Gandhi Agricultural University, Raipur (India). 2002;78–85. 

22. Lobay D. Rauwolfia in the Treatment of Hypertension. Integr Med (Encinitas). 2015;14(3):40–46. 

23. Kennedy David O. "The Deliriants – The Nightshade (Solanaceae) Family". Plants and the Human Brain. New York: Oxford University Press. 2014. pp. 131–137. 

24. Fatur, Karsten. ""Hexing Herbs" in Ethnobotanical Perspective: A Historical Review of the Uses of Anticholinergic Solanaceae Plants in Europe". Economic Botany. 2020;74(2):140–158. 

25. Pokrywka Andrzej, Obmiński Zbigniew, Malczewska Lenczowska. "Insights into supplements with Tribulus terrestris used by athletes". Journal of Human Kinetics. 2014;41(1):99–105. 

26. Ashok kumar K, Murugan M, Dhanya MK. Botany, traditional uses, phytochemistry and biological activities of cardamom [Elettaria cardamomum (L.) Maton]–A critical review. Journal of ethnopharmacology. 2020;246:112244. 

27. Kusters K, Belcher B. Eds. Forest products, livelihoods and conservation: Case studies of non–timber forest product systems. CIFOR. 2004;1. 

28. Zheng X, Xiong J, Zhang Y, et al. Multistate Markov model application for blood pressure transition among the Chinese elderly population: a quantitative longitudinal study. BMJ open. 2022;12(7):e059805. 

29. Benjamin EJ, Muntner P, Alonso A, et al. American Heart Association Council on Epidemiology and Prevention Statistics Committee and Stroke Statistics Subcommittee. Heart disease and stroke statistics—2019 update: a report from the American Heart Association. Circulation. 2019;139(10):e56–e528. 

30. Hermida RC, Ayala DE, Fernandez JR. Hypertension: New perspective on its definition and clinical management by bedtime therapy substantially reduces cardiovascular disease risk. European journal of clinical investigation. 2018;48(5): e12909. 

31. Shiovitz TM, Bain EE, McCann DJ. Mitigating the effects of non adherence in clinical trials. The journal of clinical pharmacology. 2016;56(9):1151–1164. 

32. Nieuwlaat R, Wilczynski N, Navarro T. Interventions for enhancing medication adherence. Cochrane database of systematic reviews. 2014;11. 

33. Kurtul S, AK FK, Türk M. The prevalence of hypertension and influencing factors among the employees of a university hospital. Afr Health Sci. 2020;20(4):1725–1733. 

34. Dhingra D, Dabas A. Global Strategy on Digital Health. Indian Pediatr. 2020;57(4):356–358. 

35. Bourke CA, Stevens GR, Carrigan MJ. "Locomotor effects in sheep of alkaloids identified in Australian Tribulus terrestris". Australian Veterinary Journal. 1992;69(7):163–165. 

36. Eriksson N, Wu S, Do CB. "A genetic variant near olfactory receptor genes influences cilantro preference". Flavour. 2012;1. 

37. Burdock George A, Carabin, Ioana G. "Safety Assessment of Coriander (Coriandrum sativum L.) Essential Oil as a Food Ingredient". Food and Chemical Toxicology. 2009;47(1):22–34. 

38. Popa CL, Lupitu A, Mot MD, et al. Chemical and Biochemical Characterization of Essential Oils and Their Corresponding Hydrolats from Six Species of the Lamiaceae Family. Plants (Basel). 2021;10(11):2489. 

39. Ramawat KG, Mérillon JM. Natural Products: Phytochemistry, Botany and Metabolism of Alkaloids, Phenolics and Terpenes. Springer; Berlin/Heidelberg, Germany: 2013. 

40. Nongdam P, Tikendra L. The Nutritional Facts of Bamboo Shoots and Their Usage as Important Traditional Foods of Northeast India. Int Sch Res Notices. 2014;2014:679073. 

41. Yasodha R, Kamala S, Kumar SPA. Effect of glucose on in vitro rooting of mature plants of Bambusa nutans. Scientia Horticulturae. 2008;116(1):113–116. 

42. Angiosperm Phylogeny Group. "An update of the Angiosperm Phylogeny Group classification for the orders and families of flowering plants: APG III" (PDF). Botanical Journal of the Linnean Society. 2009;161(2):105–121. 

43. Stevens Peter F. "Home". Angiosperm Phylogeny Website, Version 9. Missouri Botanical Garden. 2001. 

44. Sarah Turner, Christine Bonnin, Jean Michaud. Frontier Livelihoods: Hmong in the Sino–Vietnamese Borderlands. Seattle: University of Washington Press, 2017. pp. 104–124.